Skip to main content
Ambu logo

Ambu — Investor Relations & Filings

Ticker · AMBU ISIN · DK0060946788 LEI · 5299008W2A69WX355710 CO Manufacturing
Filings indexed 1,333 across all filing types
Latest filing 2009-07-01 Legal Proceedings Report
Country DK Denmark
Listing CO AMBU

Ambu is a global medical technology company that develops, manufactures, and markets single-use medical devices. A pioneer and market leader in single-use endoscopy, the company provides a broad portfolio of solutions for healthcare professionals across various clinical areas, including endoscopy, anesthesia, and patient monitoring. Its key products include the aScope™ line of single-use flexible endoscopes for pulmonology, gastroenterology, and urology, as well as video laryngoscopes. Ambu's solutions are designed to improve patient safety by eliminating the risk of cross-contamination associated with reusable devices, while also enhancing workflow efficiency in clinical environments by ensuring sterile, high-quality equipment is always available.

Recent filings

Filing Released Lang Actions
Legal Proceedings Report 2009
Legal Proceedings Report Classification · 99% confidence The document text is a short announcement written in Danish concerning a legal ruling in a patent lawsuit between LMA and Ambu in the US District Court. It details the outcome for specific product families (non-infringement) and notes that other claims and counterclaims are proceeding to trial on December 7, 2009. This content directly relates to significant lawsuits and regulatory/legal matters involving the company. Based on the definitions, this fits best under 'Legal Proceedings Report' (LTR). The document is short and appears to be an immediate update rather than a comprehensive legal filing or report itself.
2009-07-01 Danish
Regulatory Filings 2009
Regulatory Filings Classification · 85% confidence The document is a press release written in Danish announcing the introduction of a new single-use videoscope product, the Ambu aScopeTM, by the company Ambu. It details the product's features, its use case in anesthesia, quotes the CEO, and provides market context and launch timing (Summer/Autumn 2009). This type of announcement, focusing on a new product launch and strategic update, is best classified as a general announcement or potentially an Investor Presentation (IP) if it were more structured for investors, or an Earnings Release (ER) if it contained financial results. Since it is a specific product launch announcement that doesn't fit the strict definitions of 10-K, IR, or ER (which usually focus on period results), and it is not a formal regulatory filing like DIRS or DIV, it falls under a general corporate announcement. Given the options, and since it's a significant corporate development announcement, it is most closely aligned with a general regulatory announcement or a specific type of corporate update. However, none of the codes perfectly capture a 'Product Launch Announcement'. Comparing the definitions, it is not a financial report (10-K, IR), not a management change (MANG), not a shareholder vote result (DVA), and not a financing event (CAP). It is a general corporate news item. In the absence of a specific 'Product Launch' code, the most appropriate fallback for a significant, non-financial-results-focused corporate announcement that is not a standard regulatory form is 'Regulatory Filings' (RNS) as a broad category for corporate news releases, or potentially 'Investor Presentation' (IP) if we interpret the detailed product description as investor material. Given the nature of the text (a press release about a new product), RNS (Regulatory Filings/General Announcement) is the safest general classification for non-standard corporate news.
2009-06-04 Danish
Regulatory Filings 2009
Regulatory Filings
2009-05-11 English
Regulatory Filings 2009
Regulatory Filings
2009-05-11 Danish
Regulatory Filings 2009
Regulatory Filings
2009-05-07 English
Regulatory Filings 2009
Regulatory Filings
2009-05-07 Danish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.